J P A Ioannidis Selected Research

J P A Ioannidis Research Topics

3	Seizures (Absence Seizure) 12/2010 - 07/2005
2	Neoplasms (Cancer) 01/2014 - 06/2003
2	Osteoporosis 01/2014 - 03/2011
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 07/2005 - 07/2005
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2014
1	Infections 04/2011
1	Communicable Diseases (Infectious Diseases) 03/2011
1	Chorea (Rheumatic Chorea) 12/2010
1	Optic Neuritis (Retrobulbar Neuritis) 12/2010
1	Cognitive Dysfunction 12/2010
1	Psychotic Disorders (Schizoaffective Disorder) 12/2010
1	Transverse Myelitis (Necrotizing Myelitis) 12/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2010
1	Alcohol Withdrawal Seizures 07/2005
1	Systemic Scleroderma (Systemic Sclerosis) 09/2004
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2003
1	Atherosclerosis 05/2003
1	Rheumatoid Arthritis 05/2003
1	Rheumatic Diseases (Rheumatism) 02/2003
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2002

2	VaccinesIBA 04/2011 - 03/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2004 - 07/2002
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2014
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2014
1	Antihypertensive Agents (Antihypertensives)IBA 01/2014
1	Rituximab (Mabthera)FDA Link 04/2011
1	Immunomodulating AgentsIBA 04/2011
1	Genetic Markers (Genetic Marker)IBA 03/2011
1	GlucocorticoidsIBA 12/2010
1	Antiphospholipid AntibodiesIBA 12/2010
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2005
1	BenzodiazepinesIBA 07/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2003
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 05/2003
1	Methylprednisolone FDA LinkGeneric 05/2003
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2003
1	SteroidsIBA 05/2003
1	LipidsIBA 05/2003
1	oxidized low density lipoproteinIBA 05/2003
1	AntibodiesIBA 05/2003
1	AutoantibodiesIBA 02/2003

2	Therapeutics 02/2014 - 06/2003
1	Drug Therapy (Chemotherapy) 11/2003